Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Discover yearly leaders among index funds and understand how performance shifts across periods, helping you choose resilient options.
27,236 articlesWhen a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
Arm Holdings sparked a rally as investors eyed its AI push and the Arm Everywhere event. This article breaks down why...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Retirement calculators often misvalue pensions, skewing withdrawal plans. A real-world look at how to adjust strategy...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
Broadcom and Marvell delivered AI-fueled earnings, but the race to sustain AI momentum hinges on scale, software, and...
A rising AI-driven marketing platform secures a NASDAQ ticker and raises over $50 million, signaling a new wave of in...
Deed theft and fraudulent lien schemes are on the rise, quietly threatening homeowners. This guide breaks down how th...
In the wake of a $36 million breach, Humanity Protocol shifts from consumer crypto services to enterprise AI, led by ...
SLV rose again this week as bearish chatter on social boards quieted and options hedging nudged the silver-focused ET...